The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
934
October 28, 1994
View Complete Issue         Table of Contents 2019 
Famciclovir for Herpes Zoster
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Famciclovir for Herpes Zoster
October 28, 1994 (Issue: 934)
Famciclovir (Famvir - SmithKline Beecham) is now available in the USA for oral treatment of acute uncomplicated herpes zoster (shingles). The manufacturer claims that use of the drug reduces the duration of postherpetic neuralgia. Famciclovir is...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Famciclovir for Herpes Zoster
Article code: 934a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.